August 2018 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for August 2018. This roundup includes the latest research news from […]

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Ground Chuck Products Recalled by Publix Super Markets

FRIDAY, Aug. 31, 2018 (HealthDay News) — Possible Escherichia coli contamination has triggered the recall of ground beef products made from chuck that were sold at Publix Super Markets in Florida.

More Information

Excess Cardiac Risk Varies With Age of Onset of T1DM

FRIDAY, Aug. 31, 2018 (HealthDay News) — Excess cardiovascular risk varies with age at diagnosis of type 1 diabetes, according to a study published online Aug. 27 in The Lancet.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Medicaid Expansion Ups Access to Family Planning Services

FRIDAY, Aug. 31, 2018 (HealthDay News) — One-third of women of reproductive age report better ability to access birth control and family planning services with Medicaid expansion coverage, according to a study published online Aug. 31 in JAMA Network Open.

Abstract/Full Text

Medical Bills in Collections Decrease With Patient Age

FRIDAY, Aug. 31, 2018 (HealthDay News) — Medical collections decrease substantially with age, possibly because of increased health insurance coverage and incomes, according to a study published in the August issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

FDA: Common Diabetes Meds Tied to Serious Genital Infection

THURSDAY, Aug. 30, 2018 (HealthDay News) — A rare but serious genital infection known as necrotizing fasciitis of the perineum, also called Fournier’s gangrene, has been reported in some patients taking a certain class of type 2 diabetes medicine, according to the U.S. Food and Drug Administration. As a result, the FDA has ordered a new warning about this risk to be added to the prescribing information and patient medication guide of all sodium-glucose cotransporter-2 (SGLT2) inhibitors.

More Information

Oral High-Risk HPV Prevalence Appears to Be Low in England

THURSDAY, Aug. 30, 2018 (HealthDay News) — The prevalence of oral high-risk human papillomavirus (HR-HPV) infection in adult men and women is low in England, according to a study published online Aug. 20 in BMJ Open.

Abstract/Full Text

No Meaningful Increase in Physician Compensation Last Year

THURSDAY, Aug. 30, 2018 (HealthDay News) — There was no meaningful increase in physician compensation in 2017, and a decline in productivity was noted, according to the results of a survey conducted by AMGA Consulting.

Press Release
Survey (subscription or payment may be required)

Label Mix-Up Spurs Recall of Accord Blood Pressure Meds

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16
Page 1 of 16
Next »
Top 15 Online Casinos in Österreich mit Echtgeld 2025
casino-admiral-legale-online-casino-fur-osterreichische-spieler-mit-echter-spielgarantie